The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Researchers used mice with nine different genetic backgrounds to identify factors influencing eye aging, paving the way for eye-based diagnostics for neurodegenerative diseases.

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

AI has demonstrated remarkable proficiency in diagnosing various eye diseases, including diabetic retinopathy, glaucoma, and ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some individuals experience more severe decline than others?

Although AI shows significant promise in diagnosing and managing age-related macular degeneration, its efficacy is reduced by ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

A groundbreaking study by the Walter and Eliza Hall Institute employs AI to map retinal thickness, unveiling links to ...

Retinal thickness could be an early indicator of diseases such as Type 2 diabetes and dementia, according to study by a team ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.